A systematic review of the safety of non-tumour necrosis factor inhibitor and targeted synthetic drugs in rheumatic disease in pregnancy

Clin Med (Lond). 2020 Mar;20(Suppl 2):s98. doi: 10.7861/clinmed.20-2-s98.

Authors

Kawser Ahmed¹, Ian Giles², Hanh Nguyen², Julia Flint³

Affiliations

¹ UCL Medical School, London, UK.
² University College London Hospitals NHS Foundation Trust, London, UK.
³ Queen Elizabeth Hospital, Birmingham, UK.

No abstract available

Publication types

Systematic Review

MeSH terms

Antirheumatic Agents* / adverse effects
Female
Humans
Pregnancy
Rheumatic Diseases* / drug therapy
Synthetic Drugs* / therapeutic use
Tumor Necrosis Factor-alpha / therapeutic use

Substances

Antirheumatic Agents
Synthetic Drugs
Tumor Necrosis Factor-alpha